Skip to main content
Premium Trial:

Request an Annual Quote

Caliper Reports Increased Revenue, Contracted R&D in Q4

NEW YORK, Feb. 6 - Caliper Technologies on Wednesday reported widened net losses for the fourth quarter 2001 despite a 58 percent increase in revenue and a contraction in R&D spending.


Total revenue for the period ended Dec. 31 was $7.9 million compared with $5 million in the year-ago quarter, Caliper said in a statement. The increase was fueled largely by a $2.8 million surge in sales of its high-throughput instruments and its LabChip kits that pulled product revenue to $4 million in the quarter.


R&D spending fell to $9.9 million from $10.8 million one year ago. Despite this the company posted a net loss for the period of $8 million, or $.33 per share, compared with $5.8 million, or $.25, year over year.


Caliper said it had roughly $166 million in the bank as of Dec. 31.


Furthermore, the company said, "As anticipated, Caliper's conversion to a commercial products business from a fee-based business model resulted in Technology Access Program revenue [in the current fourth quarter] declines of 50 percent" over the same period last year.

According to Jim Knighton, Caliper's executive vice president and CFO, the company is "entering 2002 well-positioned for further revenue growth and, while we expect expenses (including cost of goods) to increase, we expect them to do so at a significantly lesser rate than revenues."


In December last year, Caliper signed a deal with Bacterial BarCodes  to develop and co-distribute a clinical diagnostic system to detect and diagnose invasive bacterial infections.


It was the first commercial diagnostics deal for Mountain View, Calif.-based Caliper, the company said.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.